Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated:  10/19/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated: 10/19/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated:  10/19/2017
Palmetto Health Richland
mi
from
Columbia, SC
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated: 10/19/2017
Palmetto Health Richland
mi
from
Columbia, SC
Click here to add this to my saved trials
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated:  10/19/2017
Ben Taub General Hospital
mi
from
Houston, TX
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated: 10/19/2017
Ben Taub General Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated:  10/19/2017
Texas Children's Hospital
mi
from
Houston, TX
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated: 10/19/2017
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated:  10/19/2017
University of Virginia
mi
from
Charlottesville, VA
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated: 10/19/2017
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated:  10/19/2017
Virginia Commonwealth University
mi
from
Richmond, VA
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated: 10/19/2017
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated:  10/19/2017
Marshall Health
mi
from
Huntington, WV
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated: 10/19/2017
Marshall Health
mi
from
Huntington, WV
Click here to add this to my saved trials
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated:  10/19/2017
University of Texas Southwestern
mi
from
Dallas, TX
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated: 10/19/2017
University of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated:  10/19/2017
Washington University
mi
from
Saint Louis, MO
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated: 10/19/2017
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated:  10/19/2017
Vidant Medical Center
mi
from
Greenville, NC
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated: 10/19/2017
Vidant Medical Center
mi
from
Greenville, NC
Click here to add this to my saved trials
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated:  10/19/2017
Lehigh Valley Hospital Center
mi
from
Allentown, PA
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated: 10/19/2017
Lehigh Valley Hospital Center
mi
from
Allentown, PA
Click here to add this to my saved trials
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated:  10/19/2017
Medical University of South Carolina
mi
from
Charleston, SC
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated: 10/19/2017
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated:  10/19/2017
St. Joseph Regional Health Center
mi
from
Bryan, TX
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated: 10/19/2017
St. Joseph Regional Health Center
mi
from
Bryan, TX
Click here to add this to my saved trials
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated:  10/19/2017
Scott & White Hospital
mi
from
Temple, TX
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® vs Placebo With Rescue Treatment for Copperhead Snake Envenomation
Status: Enrolling
Updated: 10/19/2017
Scott & White Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
Cardiovascular Prevention for Persons With HIV
Cardiovascular Disease Risk Reduction for Persons With HIV Infection: a Polypill Pilot Study
Status: Enrolling
Updated:  10/19/2017
Hennepin County Medical Center
mi
from
Minneapolis, MN
Cardiovascular Prevention for Persons With HIV
Cardiovascular Disease Risk Reduction for Persons With HIV Infection: a Polypill Pilot Study
Status: Enrolling
Updated: 10/19/2017
Hennepin County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
Treatment of Hepatic Encephalopathy With Benzodiazepine Antagonist (Flumazenil) and Change in Cortical GABA Levels in Localized 1H-MR Spectroscopy
Status: Enrolling
Updated:  10/20/2017
Yale Psychological Medicine Research Center
mi
from
New Haven, CT
Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
Treatment of Hepatic Encephalopathy With Benzodiazepine Antagonist (Flumazenil) and Change in Cortical GABA Levels in Localized 1H-MR Spectroscopy
Status: Enrolling
Updated: 10/20/2017
Yale Psychological Medicine Research Center
mi
from
New Haven, CT
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated:  10/20/2017
Coastal Clinical Research Inc
mi
from
Mobile, AL
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated: 10/20/2017
Coastal Clinical Research Inc
mi
from
Mobile, AL
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated:  10/20/2017
Paradigm Research
mi
from
Redding, CA
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated: 10/20/2017
Paradigm Research
mi
from
Redding, CA
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated:  10/20/2017
Paradigm Research
mi
from
San Diego, CA
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated: 10/20/2017
Paradigm Research
mi
from
San Diego, CA
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated:  10/20/2017
Johnson County Clinical Trials
mi
from
Lenexa, KA
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated: 10/20/2017
Johnson County Clinical Trials
mi
from
Lenexa, KA
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated:  10/20/2017
Heartland Research Associates
mi
from
Newton, KA
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated: 10/20/2017
Heartland Research Associates
mi
from
Newton, KA
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated:  10/20/2017
The Center for Pharmaceutical Research, P.C.
mi
from
Kansas City, MO
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated: 10/20/2017
The Center for Pharmaceutical Research, P.C.
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated:  10/20/2017
Meridien Clinical Research
mi
from
Omaha, NE
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated: 10/20/2017
Meridien Clinical Research
mi
from
Omaha, NE
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated:  10/20/2017
Medical Research South
mi
from
Charleston, SC
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated: 10/20/2017
Medical Research South
mi
from
Charleston, SC
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated:  10/20/2017
Benchmark Research
mi
from
Austin, TX
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated: 10/20/2017
Benchmark Research
mi
from
Austin, TX
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated:  10/20/2017
Benchmark Research
mi
from
Fort Worth, TX
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated: 10/20/2017
Benchmark Research
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated:  10/20/2017
Sundance Clinical Research, LLC
mi
from
Saint Louis, MO
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat
An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects
Status: Enrolling
Updated: 10/20/2017
Sundance Clinical Research, LLC
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated:  10/23/2017
Infectious Disease Specialists of Atlanta
mi
from
Atlanta, GA
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated: 10/23/2017
Infectious Disease Specialists of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated:  10/23/2017
Lake Internal Med. Assoc.
mi
from
Eustis, FL
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated: 10/23/2017
Lake Internal Med. Assoc.
mi
from
Eustis, FL
Click here to add this to my saved trials
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated:  10/23/2017
The Research Center
mi
from
Hialeah, FL
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated: 10/23/2017
The Research Center
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated:  10/23/2017
JDH Medical Group
mi
from
Miami, FL
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated: 10/23/2017
JDH Medical Group
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated:  10/23/2017
St Lucie Medical Center
mi
from
Port Saint Lucie, FL
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated: 10/23/2017
St Lucie Medical Center
mi
from
Port Saint Lucie, FL
Click here to add this to my saved trials
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated:  10/23/2017
Tampa Genereal Hospital
mi
from
Tampa, FL
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated: 10/23/2017
Tampa Genereal Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated:  10/23/2017
Kentucky Lung Clinic, PSC
mi
from
Hazard, KY
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated: 10/23/2017
Kentucky Lung Clinic, PSC
mi
from
Hazard, KY
Click here to add this to my saved trials
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated:  10/23/2017
Bronson Methodist Hosp. Ped
mi
from
Kalamazoo, MI
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated: 10/23/2017
Bronson Methodist Hosp. Ped
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated:  10/23/2017
William Beaumont Hospital
mi
from
Troy, MI
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated: 10/23/2017
William Beaumont Hospital
mi
from
Troy, MI
Click here to add this to my saved trials
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated:  10/23/2017
University of Missouri- Clinical Research Center
mi
from
Columbia, MO
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated: 10/23/2017
University of Missouri- Clinical Research Center
mi
from
Columbia, MO
Click here to add this to my saved trials
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated:  10/23/2017
Washington Univ School of Med
mi
from
Saint Louis, MO
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated: 10/23/2017
Washington Univ School of Med
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated:  10/23/2017
Westmead Hospital
mi
from
Northmead,
A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus-Related Illness
Status: Enrolling
Updated: 10/23/2017
Westmead Hospital
mi
from
Northmead,
Click here to add this to my saved trials
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated:  10/23/2017
GSK Investigational Site
mi
from
Mobile, AL
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated: 10/23/2017
GSK Investigational Site
mi
from
Mobile, AL
Click here to add this to my saved trials
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated:  10/23/2017
GSK Investigational Site
mi
from
Long Beach, CA
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated: 10/23/2017
GSK Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated:  10/23/2017
GSK Investigational Site
mi
from
Torrance, CA
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated: 10/23/2017
GSK Investigational Site
mi
from
Torrance, CA
Click here to add this to my saved trials
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated:  10/23/2017
GSK Investigational Site
mi
from
Jacksonville, FL
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated: 10/23/2017
GSK Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated:  10/23/2017
GSK Investigational Site
mi
from
Council Bluffs, IA
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated: 10/23/2017
GSK Investigational Site
mi
from
Council Bluffs, IA
Click here to add this to my saved trials
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated:  10/23/2017
GSK Investigational Site
mi
from
Topeka, KA
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated: 10/23/2017
GSK Investigational Site
mi
from
Topeka, KA
Click here to add this to my saved trials
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated:  10/23/2017
GSK Investigational Site
mi
from
New Orleans, LA
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated: 10/23/2017
GSK Investigational Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated:  10/23/2017
GSK Investigational Site
mi
from
Las Vegas, NV
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated: 10/23/2017
GSK Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated:  10/23/2017
GSK Investigational Site
mi
from
Buffalo, NY
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated: 10/23/2017
GSK Investigational Site
mi
from
Buffalo, NY
Click here to add this to my saved trials
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated:  10/23/2017
GSK Investigational Site
mi
from
Columbus, OH
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated: 10/23/2017
GSK Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated:  10/23/2017
GSK Investigational Site
mi
from
Lima, OH
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated: 10/23/2017
GSK Investigational Site
mi
from
Lima, OH
Click here to add this to my saved trials